| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15K | — | — |
| R&D Expense | $357K | — | +291.3% |
| SG&A Expense | $4.2M | — | +111.1% |
| Pre-tax Income | -$6.4M | — | -222.0% |
| Net Income | -$6.4M | — | -222.0% |
| EPS (Basic) | -$0.18 | — | -157.1% |
| EPS (Diluted) | -$0.18 | — | -157.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $2.8M | — | — |
| Accounts Receivable | $5K | +0.0% | — |
| Current Assets | $8.8M | +279.1% | +13.8% |
| Total Assets | $15.5M | +41.7% | +92.0% |
| Current Liabilities | $11.3M | +67.3% | +455.1% |
| Total Liabilities | $12.9M | +52.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.9M | — | -436.0% |
| Capital Expenditures | $220K | — | +7680.6% |
| Investing Cash Flow | -$3.1M | — | — |
| Financing Cash Flow | $9.6M | — | +1237.7% |
| Free Cash Flow | -$3.2M | — | -473.4% |
| +532.2% |
| Stockholders' Equity | $2.6M | +5.7% | -56.6% |